MedTrace Logo

Perception of Efficacy, Safety and Tolerability of Three Non-hormonal Intravaginal Gels and Hormone Cream

NCT02987647 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2016-12-09

No results posted yet for this study

Summary

To evaluate the perception of the effectiveness of Hidrafemme® gels, Vagidrat®, Lubrinat and Antrofi cream in improving vaginal moisture in postmenopausal women who are currently registered options most current and available in the market in order to assess the differences between them, subsequently conduct a clinical study larger.

Conditions

  • Vaginal Dryness

Interventions

OTHER

Hidrafemme

The complete treatment will have followed four weeks of duration and application of the product should take place twice a week.

OTHER

Vagidrat

The complete treatment will have followed four weeks of duration and application of the product should take place twice a week.

OTHER

Lubrinat

The complete treatment will have followed four weeks of duration and application of the product should take place twice a week.

OTHER

Antrofi

The complete treatment will have followed four weeks of duration and application of the product should take place twice a week.

Sponsors & Collaborators

  • Farmoquimica S.A.

    lead INDUSTRY

Principal Investigators

  • Thales Braga, analist · FQM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-03-31
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02987647 on ClinicalTrials.gov